ESOPApr 15, 2026, 04:05 PM
Acrivon Grants 111,150 Stock Options as Inducement to Employee
AI Summary
Acrivon Therapeutics, Inc. announced the approval of an equity award grant to one employee under its 2023 Inducement Plan. The grant, effective April 15, 2026, consists of options to purchase 111,150 shares of common stock. These options were granted as a material inducement to employment and will vest over four years, with 25% vesting on the first anniversary and monthly thereafter.
Key Highlights
- Granted options to purchase 111,150 shares of common stock.
- Grant date was April 15, 2026.
- Options vest 25% on first anniversary, then monthly over three years.
- Exercise price equals closing price on grant date.
- Award is an inducement for new employee's employment.
Price Impact
More from ACRV